Biopharmaceutical company.
H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors; S. 275 / H.R. 605, the Medicare Home Infusion Site of Care Act of 2015 and issues related to reimbursement for infused drugs administered through DME. Issues related to pharmaceutical prices, including the Part B Demonstration. Issues related to corporate tax reform and the taxation of U.S. multinational corporations. Issues related to corporate mergers. H.R. 6, The 21st Century Cures Act and the Innovations Initiative. Issues concerning care for chronic disease patients.
MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
MARY BETH SAVARY TAYLOR EMILY PORTER RACHEL JONES HENSLER MARY BETH SAVARY TAYLOR EMILY PORTER MARY BETH SAVARY TAYLOR EMILY PORTER